Sales, Baby Girl .
HRN: 25-50-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/20/2024
07/26/2024
IV
45
Q24
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes